TREA

90805745 - DUAL-IG

Follow

Information

  • Trademark
  • 90805745
  • Serial Number
    90805745
  • Registration Number
    6927710
  • Filing Date
    July 01, 2021
    3 years ago
  • Registration Date
    December 20, 2022
    2 years ago
  • Transaction Date
    December 20, 2022
    2 years ago
  • Status Date
    December 20, 2022
    2 years ago
  • Published for Opposition Date
    July 26, 2022
    2 years ago
  • Location Date
    December 20, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HARDY LUDLOW, TARAH KI
  • Attorney Docket Number
    1034347-555
    Attorney Name
    Bassam N. Ibrahim
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
DUAL-IG
Case File Statements
  • GS0051: Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for use in the treatment or prevention of infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use
  • GS0451: Granting of licenses to others for the use of industrial property rights and copyright
  • GS0421: Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Case File Event Statements
  • 12/20/2022 - 2 years ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/20/2022 - 2 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/14/2022 - 2 years ago
    20 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 10/28/2022 - 2 years ago
    19 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 11/14/2022 - 2 years ago
    18 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/28/2022 - 2 years ago
    17 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 9/20/2022 - 2 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/26/2022 - 2 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/26/2022 - 2 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/6/2022 - 2 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/22/2022 - 2 years ago
    12 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 6/17/2022 - 2 years ago
    11 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 6/13/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/11/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/10/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/10/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/23/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/23/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/23/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/23/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/13/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/5/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP